产学研合作模式下长三角生物医药产业一体化协同创新发展研究——基于专利合作及基金项目合作

万里; 孙劲楠; 丁佐奇; 郝海平

doi:10.11665/j.issn.1000-5048.20220614

产学研合作模式下长三角生物医药产业一体化协同创新发展研究——基于专利合作及基金项目合作

1.
中国药科大学国际医药商学院,南京 211198
2.
中国药科大学《中国天然药物》编辑部，南京 210009
3.
中国药科大学药学院，南京 211198

基金项目: 2022年江苏省科协调研课题资助（No.JSKXKT 2022018）；中国药科大学“十四五”发展战略暨全面深化改革研究2022年度课题资助

计量
- 文章访问数: 210
- HTML全文浏览量: 8
- PDF下载量: 369
出版历程
- 收稿日期: 2022-10-27
- 修回日期: 2022-11-27
- 刊出日期: 2022-12-24

Research on the development of bio-pharmaceutical industry integration and collaborative innovation in the Yangtze River Delta under the mode of Industry-University-Research cooperation

1.
School of International Pharmaceutical Business, China Pharmaceutical University,Nanjing 211198
2.
Editorial Board of Chinese Journal of Natural Medicines, China Pharmaceutical University, Nanjing 210009
3.
School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China

Funds: This study was supported by the Subject of Jiangsu Provincial Science Association Research in 2022 （No.JSKXKT 2022018） and the Development Strategy of China Pharmaceutical University during the Fourteenth Five-Year Plan and the Subject of Comprehensively Deepening Reform Research in 2022

摘要

摘要: 长三角一体化上升并发展为国家战略后，国内鲜有探讨长三角地区生物医药产业一体化协同发展的研究，长三角作为我国生物医药产业的重要地区，已初步形成产业集群的发展模式。本研究基于专利及基金项目合作的产学研模式，利用社会网络分析方法（SNA）对长三角地区生物医药产业中专利和国家自然科学基金重大项目合作进行分析研究。研究表明，长三角地区生物医药领域的产学研合作还处于发展阶段，一体化程度也有待提高；高校及科研院所更倾向于与企业合作开展发明专利，与高校合作开展基金项目研究。长三角地区三省一市间的生物医药产业发展也存在一定差距，建议长三角地区采取产学研深度融合模式，相关龙头科研机构建立开放式创新平台，医药类高校借助学科优势培养创新型人才，采取“揭榜挂帅”等方式进行关键核心技术攻关。
- 长三角一体化 /
- 生物医药产业 /
- 产学研合作 /
- 合作发明专利 /
- 国家自然科学基金重大项目
Abstract: After the integration of Yangtze River Delta was elevated and developed into a national strategy, few domestic studies have been conducted to explore the integrated and collaborative development of biopharmaceutical industry in the Yangtze River Delta region, which, as an important region of biopharmaceutical industry in China, has initially formed the development mode of industrial clusters. In this study, based on the industry-university-research model of patent and fund project cooperation, the social network analysis (SNA) method is used to analyze and study the cooperation of patent and Major Projects of National Natural Science Foundation of China in the biopharmaceutical industry in the Yangtze River Delta region. The study shows that the industry-university-research cooperation in the biomedical field in the Yangtze River Delta region is still in the development stage and the degree of integration needs to be improved. Universities and research institutes are more inclined to cooperate with enterprises for invention patents and with other universities for fund project research.It is suggested that the Yangtze River Delta region should adopt the deep integration mode of industry-university-research, relevant leading scientific research institutions should establish open innovation platforms, and pharmaceutical universities should cultivate innovative talents with the advantages of their disciplines, and adopt "Revealing the List and Taking Command" or other ways to tackle key core technologies.

HTML全文

参考文献(21)

[1]	. People's Daily（人民日报），2021-03-13（001）.
[2]	National Development and Reform Commission. The 14th Five-Year Plan for the development of bioeconomy［A/OL］. （2021-12-20）［2022-10-07］. https：//www.ndrc.gov.cn/xwdt/tzgg/202205/P020220510324283427632.pdf.
[3]	Liu ZB，Chen L. Demonstration value and motivation mechanism of regional integration development in the Yangtze River Delta Region［J］. Reform（改革），2018（12）：65-71.
[4]	The State Council of the People's Republic of China. Outline of the Yangtze River Delta Regional Integrated Development Plan ［EB/OL］. （2019-12-01）［2022-10-07］．http：//www.gov.cn/zhengce/2019/12/01/content_5457442.html.
[5]	Ministry of Science and Technology of the People′s Republic of China. Notice of the Ministry of Science and Technology on the issuance of the yangtze river delta science and technology innovation community construction and development plan［EB/OL］. （2020-12-20）［2022-10-07］. https：//www.most.gov.cn/xxgk/xinxifenlei/fdzdgknr/fgzc/gfxwj/gfxwj2020/202101/t20210113_172235.html.
[6]	Tang CL，Gu X. Research on the source and formation of knowledge advantage of Industry-University-Research Cooperation Innovation Network［J］. Scie Technol Manag Res （科技管理研究），2010，30（11）：113-116.
[7]	Suzhou Industrial Park Management Committee. Yangtze River Delta Biomedical Industry Chain Alliance established in Suzhou Industrial Park［EB/OL］. （2021-05-25）［2022-10-07］. http：//www.suzhou.gov.cn/szsrmzf/qxkx/202105/43f7b410a0a0488d95d37e474675b18d.shtml.
[8]	Shanghai Municipal Commission of Economy and Information Technology. Implementation plan on promoting the development of biomedical industrial park features［A/OL］. （2020-10-22）［2022-10-07］. http：//sheitc.sh.gov.cn/cmsres/c1/c1ca71efc 0994c7e8c0d64bc1e8070f1/ed2a2092d1d182d37d33e168f2ac5e1f.pdf.
[9]	General Office of Zhejiang Provincial People's Government on the issuance of action plans to promote the high-quality development of biomedical industry （2022-2024）［J］. Gazette of the People's Government of Zhejiang Province（浙江省人民政府公报），2022（17）：20-25.
[10]	Xu P. The Research on the Development Status and Countermeasures of Anhui's Biomedical Industry［J］. Value Eng（价值工程），2014，33（4）：151-152.
[11]	Ministry of Science and Technology of the People's Republic of China. 2021 China Biomedical Industrial Park Competitive Evaluation and Analysis Report［EB/OL］. （2021-11-04）［2022-10-07］. https：//www.most.gov.cn/kjbgz/202111/t20211104_177831.html.
[12]	Shanghai Technology Exchange. Report on The Development of Regional Innovation Institutions in the Yangtze River Delta［EB/OL］. （2022-09-28）［2022-10-07］. http：//www.stte.com/articles/776.
[13]	The Organization Department of the Central Committee of the CPC. Notice on the issuance of the opinions on strengthening and Improving the party construction work of research institutes［EB/OL］. （2000-06-30）［2022-10-07］. http：//www.irsa.cas.cn/dj/gzzd/201011/t20101124_3029158.html.
[14]	Chen YW，Fang S. Application of Social Network Analysis （SNA） on patents networks analysis［J］. Library and Information Service（图书情报工作），2012，56（4）：90-95.
[15]	Wan YY，Wang QY，Zeng G，et al. Influencing mechanism of formation of innovation network between universities and biomedical firms：a case study of Yangtze River Delta［J］. Eco Geography（经济地理），2022，42（07）：146-158.
[16]	Liu R，Wang P，Yu J，et al. Obstacles and Countermeasures of Hospital Patent Transformation in China under the Background of Translational Medicine［J］. Hosp Adm J Chin PLA（解放军医院管理杂志），2017，24（2）：141-144.
[17]	Zhang ML. Current Situation and Risk Prevention of Collaborative Innovation between Universities，Enterprises and Research Institutes［J］. China Univ Sci Technol（中国高校科技），2017（10）：29-31.
[18]	Yu XX，Fan TH，Xu LJ，et al. Exploring the development of biomedical industrial park model of domestic and foreign universities based on Industry-University-Research cooperation［J］. Sci Technol Ind China（中国科技产业），2022（01）：60-63.
[19]	TORREYA. The Pharma 1000 Top Global Pharmaceutical Company Report［A/OL］.（2021-11-18）［2022-10-07］. https：//torreya. com/publications/pharma-1000-report-update-torreya-2021-11-18.pdf.
[20]	Wan L，Sun JN，Ding ZQ，et al. Research on the implementation strategy of “Revealing the List and Domination” system in the field of medicine based on policy text analysis［J］. Pharm Edu（药学教育），2022，38（4）：1-7.
[21]	Xie WQ，Tu J，Li GQ，et al. Research on the collaborative training mechanism of diversified biomedical talents in the context of “Healthy China”［J］.J Higher Edu（高教学刊），2022，8（15）：173-176，180.

施引文献

资源附件(0)

计量

文章访问数: 210
HTML全文浏览量: 8
PDF下载量: 369
被引次数: 0

产学研合作模式下长三角生物医药产业一体化协同创新发展研究——基于专利合作及基金项目合作

计量

出版历程

Research on the development of bio-pharmaceutical industry integration and collaborative innovation in the Yangtze River Delta under the mode of Industry-University-Research cooperation

计量

出版历程

目录